new glp 1 agonist novo nordisk Nordisk's weight-loss pill wins FDA approval ADA: Novo's Wegovy pill crosses
Description
Orforglipron Improves Glucose Tolerance, Reduces Food Intake, and Lowers Adipose Tissue Weight in HFD-Induced Humanized GLP-1R Mice B-hGLP1R mice plus were fed a high-fat diet (HFD) to induce obesity, followed by Orforglipron treatment
doi: 10.1139/apnm-2020-0005
Boosting GLP-1 by Natural Products
What youll learn: Most GLP-1 receptor agonist medications are taken as daily or weekly injections
